Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 10, 2019PLoS MedicineOpen Access

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAndrew VernonCenters for Disease Control and PreventionKFKatherine FieldingUniversity of the WitwatersrandRSRada SavicCity College of San Francisco

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vernon et al. (2019) studied this question.

synapsesocial.com/papers/6aae01fd537e7deed64f67f9https://doi.org/10.1371/journal.pmed.1002884
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis2016 · 1,519 citations
  2. 2Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection2017 · 176 citations
  3. 3Tuberculosis control in resource‐poor countries: have we reached the limits of the universal paradigm?2004 · 95 citations
  4. 4Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial2019 · 235 citations
  5. 5Directly observed therapy for treating tuberculosis2015 · 665 citations